AIDS TREATMENT NEWS No. 112 - October 5, 1991
John S. James
The split came after months of increasing tension, and many people think the division will be beneficial. Both organizations are now working well, and they have begun their relationship on good terms. Some individuals will be active in both, and weekly meeting nights have been arranged to accommodate. One committee, the Youth Action Caucus of ACT UP/San Francisco, applied to also be a committee of ACT UP/Golden Gate, and was accepted. The groups are expected to work together; for example, both unanimously endorsed a call for approval of ddI and ddC before the end of the year.
Why, then, the split? The immediate issue was whether to maintain consensus, or allow decisions by an 80 percent vote. The decision to adopt voting would have had to be made by consensus, and when several people blocked that decision, the group split. (ACT UP/Golden Gate now makes decisions by a two-thirds vote, although in practice many, if not most, are unanimous.)
For both groups, demonstrations and street theater are primary tools. But ACT UP/Golden Gate also emphasizes working "within the system," as well as on the street, to get research done and make treatments available, and those who work with government agencies, pharmaceutical companies, and other mainstream organizations, want group support. ACT UP/San Francisco emphasizes the need for larger social change to end the epidemic, as well as the need for treatments. Consensus was a key issue, because giving anyone the power to block group action assured that minority voices would be heard and considered. But with 200 members with very diverse points of view (ACT UP/San Francisco had tripled in size since the June, 1990 Sixth International Conference on AIDS), it had become very difficult to get any significant action approved. Energy was increasingly devoted to process issues and infighting, instead of useful work.
Separation has freed both groups, ending paralysis, allowing productive competition, and opening the way for members who had previously left the group to now return to one or the other. Both groups will hold demonstrations in the next week (see announcement below).
The general meeting of ACT UP/San Francisco continues to be every Thursday at 7:30 PM at the Women's Building, 3543 18th St. (near Valencia). ACT UP/Golden Gate meets every Monday at 7:30 at 347 Dolores St., room 202.
901005
ATN11203
Copyright © 1990 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .